2018
DOI: 10.1111/imj.13728
|View full text |Cite
|
Sign up to set email alerts
|

Use of extracorporeal membrane oxygenation in cystic fibrosis in an Australian cystic fibrosis centre

Abstract: Extracorporeal membrane oxygenation (ECMO) support is used in selected patients with cystic fibrosis (CF) as a bridge to transplantation. Our aim was to describe briefly treatment and outcomes of six CF patients who received ECMO. One patient received a lung transplant and another recovered from acute respiratory failure. Four died despite ECMO support. Lack of timely availability of suitable donor lungs and patient selection are contributing factors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…Some of these were already on the waitlist who have deteriorated faster than expected, others were previously healthy. Prolonged periods of ECMO are associated with worse outcomes and high mortality (50), so the decision to transplant off ECMO is a critical one and must be made early (51).…”
Section: Extracorporeal Membrane Oxygenation (Ecmo)mentioning
confidence: 99%
“…Some of these were already on the waitlist who have deteriorated faster than expected, others were previously healthy. Prolonged periods of ECMO are associated with worse outcomes and high mortality (50), so the decision to transplant off ECMO is a critical one and must be made early (51).…”
Section: Extracorporeal Membrane Oxygenation (Ecmo)mentioning
confidence: 99%